IP Library Granted Patent US 8,440,451
Granted Patent B2
US 8,440,451 · App. 13/107,881 · Granted May 14, 2013

Genetically modified yeast species, and fermentation processes using genetically modified yeast

Inventors: Vineet Rajgarhia (Kingsport, TN); Kari Koivuranta (Helsinki, FI); Merja Penttilä (Helsinki, FI); Marja Ilmen (Helsinki, FI); Pirkko Suominen (Maple Grove, MN); Aristos Aristidou (Maple Grove, MN); Christopher Kenneth Miller (Cottage Grove, MN); Stacey Olson (St. Bonifacius, MN); Laura Ruohonen (Helsinki, FI)
Assignee: Cargill, Incorporated
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,440,451
App. No.
13/107,881
Granted
May 14, 2013
Kind
B2
Abstract

Yeast cells are transformed with an exogenous xylose isomerase gene. Additional genetic modifications enhance the ability of the transformed cells to ferment xylose to ethanol or other desired fermentation products. Those modifications include deletion of non-specific or specific aldose reductase gene(s), deletion of xylitol dehydrogenase gene(s) and/or overexpression of xylulokinase.

Claims (17)

1. A genetically modified yeast cell having a genome and a functional, exogenous xylose isomerase gene, wherein the exogenous xylose isomerase gene is operatively linked to promoter and terminator sequences that are functional in the yeast cell, and the modified yeast cell further has a deletion or disruption of a native gene that produces an enzyme that catalyzes the conversion of xylose to xylitol, and wherein the exogenous xylose isomerase gene encodes a xylose isomerase enzyme that is at least 90% homologous to SEQ. ID. NO. 163 and has an identities score of less than 95% compared with SEQ. ID. NO. 59 and a positives score of less than 97% compared with SEQ. ID. NO. 59.

2. The genetically modified yeast cell of claim 1 wherein the functional, exogenous xylose isomerase gene is integrated into the genome of the yeast cell.

3. The genetically modified yeast cell of claim 2 , wherein the native gene that produces an enzyme that catalyzes the conversion of xylose to xylitol is a xylose reductase gene.

4. The genetically modified yeast cell of claim 3 , further having a deletion or disruption of a native xylitol dehydrogenase gene.

5. The genetically modified yeast cell of claim 4 , which contains a functional, exogenous xylulokinase gene operatively linked to promoter and terminator sequences that are functional in the yeast cell.

6. The genetically modified yeast cell of claim 1 that is of the genera Kluyveromyces, Candida, Pichia, Brettanomyces, Pachysolen or Saccharomyces.

7. The genetically modified yeast cell of claim 1 , further having a deletion or disruption of a native pyruvate decarboxylase gene.

8. The genetically modified yeast cell of claim 7 , further having integrated into its genome a functional, exogenous lactate dehydrogenase gene, wherein the exogenous lactate dehydrogenase gene is operatively linked to promoter and terminator sequences that are functional in the yeast cell.

9. The genetically modified yeast cell of claim 1 wherein the exogenous xylose isomerase gene encodes a xylose isomerase enzyme that is at least 95% homologous to SEQ. ID. NO. 163.

10. The genetically modified yeast cell of claim 1 wherein the exogenous xylose isomerase gene encodes a xylose isomerase enzyme that is at least 98% homologous to SEQ. ID. NO. 163.

11. The genetically modified yeast cell of claim 1 wherein the exogenous xylose isomerase gene encodes a xylose isomerase enzyme that is at least 99% homologous to SEQ. ID. NO. 163.

12. The genetically modified yeast cell of claim 1 wherein the exogenous xylose isomerase gene encodes a xylose isomerase enzyme having SEQ. ID. NO. 163.

13. A genetically modified yeast cell having a genome and a functional, exogenous xylose isomerase gene, wherein the exogenous xylose isomerase gene is operatively linked to promoter and terminator sequences that are functional in the yeast cell, and the modified yeast cell further has a deletion or disruption of a native gene that produces an enzyme that catalyzes the conversion of xylose to xylitol, and wherein the exogenous xylose isomerase gene is at least 90% homologous to SEQ. ID. NO. 162.

14. The genetically modified yeast cell of claim 13 wherein the exogenous xylose isomerase gene is at least 95% homologous SEQ. ID. NO. 162.

15. The genetically modified yeast cell of claim 13 wherein the exogenous xylose isomerase gene is at least 98% homologous SEQ. ID. NO. 162.

16. The genetically modified yeast cell of claim 13 wherein the exogenous xylose isomerase gene is at least 99% homologous SEQ. ID. NO. 162.

17. The genetically modified yeast cell of claim 13 wherein the exogenous xylose isomerase gene has SEQ. ID. NO. 162.

Assignments (1)
RELEASE OF SECURITY INTEREST Recorded Oct 4, 2016
From: TRIPLEPOINT CAPITAL LLC
To: GEVO, INC.
Reel/Frame 040219/0177 →
Continuity (2)
Division 10554887
Related Publication 20110287505A1 · Nov 24, 2011